HIPEC surgery is a promising treatment option for patients with certain abdominal cancers. Surgical oncologist Erin Ward, MD, discusses which patients would be best candidates for HIPEC, explains why ...

Adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian carcinoma, ...

Ovarian cancer often goes undetected until it spreads to other areas. In its late stages, it's harder to treat. Now there's an unconventional treatment being used to get rid of it. When her stomach ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

HIPEC addition to SCS did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer patients. Both SCS alone and SCS with HIPEC groups exhibited similar safety profiles, ...

Amber and her family in the Volkswagen convertible she bought after learning she was cancer-free Amber used to live her life with anxiety and fear—always trying to stay within her comfort zone. She ...

Hyperthermic intraperitoneal chemotherapy has a debated role in advanced gastrointestinal cancers. The data from this randomized study inform that hyperthermic intraperitoneal chemotherapy following ...

Surgical lymph node clearance and pathologic evaluation in gastric cancer. Background: Peritoneal carcinomatosis is a common sign of advanced tumor stage or disease recurrence in patients with gastric ...

Median progression-free survival (PFS) improved from 23 months with surgery alone to 25 months with the addition of hyperthermic intraperitoneal chemotherapy (HIPEC), a nonsignificant difference. Post ...

SCS combined with HIPEC may improve overall survival in PSROC patients compared to SCS alone, with a statistically significant benefit observed. The risk of severe complications, including anemia and ...

From left, Dr. Vadim Guschin, Director of Mercy’s heated chemotherapy (HIPEC) program and a member of the Surgical Oncology Department, and Armando Sardi, M.D., Medical Director of The Institute for ...

They were given little hope of survival after being diagnosed with cancer, but now thanks to a little-known procedure they are continuing on with their lives. Kelly McCarley of Owings and Joe Finn of ...